跳至主要内容
临床试验/ACTRN12624000311550
ACTRN12624000311550招募中Unknown

Effectiveness and engagement with a digital insomnia treatment program in Australian pharmacy settings: A randomised controlled trial.

The Adelaide Institute for Sleep Health, Flinders University0 个研究点目标入组 100 人开始时间: 2024年3月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Pharmacist inclusion criteria:
  • 1. Currently practicing as a pharmacist in Australia.
  • Patient inclusion criteria:
  • 1. Aged at least 18
  • 2. Referred by participating pharmacist.
  • 3. Reliable access to computer, tablet or smartphone, with internet access.
  • 4. Basic English language comprehension as required for dCBTi program participation.

排除标准

  • 1. No excessive daytime sleepiness (Epworth Sleepiness Scale score score of greater than or equal to 16).
  • 2. None of the following psychiatric conditions; Bi-polar disorder, schizophrenia.
  • 3. No risk of suicide (PHQ-9; item 9 score of greater than or equal to 1).
  • 4. No Epilepsy.
  • 5. Not currently pregnant.
  • 6. No commercial drivers or people who operate heavy machinery for work.
  • 7. No people with a cognitive impairment.
  • 8. No shift-workers.
  • 9. Previous sleepiness-related motor vehicle accident.

研究者

发起方
The Adelaide Institute for Sleep Health, Flinders University

相似试验